FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Bliss GVS Pharma LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:506197 P/E (TTM) :24.57
ISIN Demat:INE416D01022 Div & Yield %:0.27 EPS (TTM) :7.41
Book Value (RS) :104.3299482 Market Cap (Rs Cr.):1926.42 Face Value (RS) :1
    Change Company 
Particulars Quarter Ended
(Sep 2025)		 Quarter Ended
(Sep 2024)		 Quarter Ended
(% Var)
Sales 190.23 182.65 4.15
Other Income 25.84 8.35 209.46
PBIDT 43.86 33.73 30.03
Interest 2.71 3.45 -21.45
PBDT 41.15 30.29 35.85
Depreciation 7.69 6.39 20.34
PBT 33.46 23.90 40.00
Tax 11.41 8.74 30.55
Deferred Tax -2.75 -1.90 0.00
PAT 24.79 17.04 45.48

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)